Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | proteasome subunit beta 1 (T01 family) | 0.0069 | 0.16 | 0.1966 |
Schistosoma mansoni | hypothetical protein | 0.0062 | 0.1351 | 0.166 |
Mycobacterium ulcerans | proteasome PrcB | 0.0231 | 0.8137 | 0.5 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0231 | 0.8137 | 1 |
Onchocerca volvulus | 0.0277 | 1 | 0.5 | |
Leishmania major | proteasome beta 5 subunit, putative | 0.0231 | 0.8137 | 1 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0069 | 0.16 | 0.1966 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.2517 | 0.2517 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0091 | 0.2517 | 0.2517 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0231 | 0.8137 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0091 | 0.2517 | 0.2517 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0231 | 0.8137 | 1 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0231 | 0.8137 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0158 | 0.5211 | 0.6404 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0231 | 0.8137 | 1 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0231 | 0.8137 | 1 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0231 | 0.8137 | 1 |
Trypanosoma brucei | proteasome beta 6 subunit | 0.0069 | 0.16 | 0.1966 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0231 | 0.8137 | 1 |
Loa Loa (eye worm) | proteasome subunit beta type 1 | 0.0069 | 0.16 | 0.16 |
Leishmania major | proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative | 0.0069 | 0.16 | 0.1966 |
Loa Loa (eye worm) | hypothetical protein | 0.0277 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0158 | 0.5211 | 0.6404 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.1351 | 0.1351 |
Plasmodium vivax | proteasome subunit beta type-1, putative | 0.0069 | 0.16 | 0.1966 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0069 | 0.16 | 0.1966 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0231 | 0.8137 | 1 |
Brugia malayi | proteasome subunit beta type 1 | 0.0069 | 0.16 | 0.16 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0231 | 0.8137 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0062 | 0.1351 | 0.1351 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0069 | 0.16 | 0.1966 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0231 | 0.8137 | 0.8137 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0231 | 0.8137 | 1 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0231 | 0.8137 | 1 |
Echinococcus granulosus | proteasome prosome macropain | 0.0231 | 0.8137 | 1 |
Toxoplasma gondii | proteasome subunit beta type 1, putative | 0.0069 | 0.16 | 0.1966 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0231 | 0.8137 | 0.5 |
Echinococcus granulosus | geminin | 0.0158 | 0.5211 | 0.6404 |
Plasmodium falciparum | proteasome subunit beta type-1, putative | 0.0069 | 0.16 | 0.1966 |
Schistosoma mansoni | hypothetical protein | 0.0158 | 0.5211 | 0.6404 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0091 | 0.2517 | 0.2517 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0231 | 0.8137 | 0.8137 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0069 | 0.16 | 0.1966 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.